Invus, a unique business transformer, aligns with partners for long-term success, managing over $4B globally since 1985.
Location
New York City, NY, US
Founded
1985
Invus is a global investment firm that empowers leaders to transform their industries. They offer flexible capital and long-term commitment, focusing on exponential, sustainable value creation across various sectors. Invus typically invests in Series A to Series D rounds, with a significant presence in later-stage investments.
The firm's portfolio includes notable companies such as Moderna, Schrodinger, and Recursion Pharmaceuticals in the biotech sector, as well as ezCater and Thrive Market in consumer services. Invus emphasizes management ownership and autonomy, providing strategic advice while allowing partners to navigate their unique paths to success. Their approach combines vision, customer insights, and a commitment to building sustainable competitive advantages.
Invus - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
